Zumutor Biologics - Crunchbase Company Profile & Funding

Q: Who invested in Zumutor Biologics?

Zumutor Biologics has 7 investors including Siana Capital Management And Accel.

Q: When was the last funding round for Zumutor Biologics?

Zumutor Biologics closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Zumutor Biologics raised to date?

Zumutor Biologics has raised obfuscated.

Overview

Zumutor Biologics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Zumutor Biologics

CB Rank

27420

Zumutor Biologics is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics.

Founded

obfuscation

Private

Series A

Woburn, Massachusetts, United States

11-50

www.zumutor.com/

Biotechnology

Oncology

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Corporate Round

OBF

obfuscation

Key People

Kavitha Iyer Rodrigues: Co-Founder & CEO
Past Role: Biocon, Team Member

Details

Legal Name

Zumutor Biologics INC

Operating Status

Active

Company Type

For Profit

Founders

Kavitha Iyer Rodrigues, Sohang Chatterjee

About the Company

Zumutor is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics. They have two proprietary Antibody Engineering Platforms to develop novel immunotherapies that target innate immunity and regulate the tumor microenvironment.

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

INABLR™ Human Antibody Platform

A proprietary technology for the rapid identification of selective and potent monoclonal antibodies to enhance ADCC activity.

ADCC Improvement Platform

Developed to enhance the antibody-dependent cellular cytotoxicity of therapeutic antibodies, with patent applications filed for global IP rights.

Research & Development

Zumutor Biologics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A
obfuscated obfuscation	Series A - Zumutor Biologics	3	obfuscated obfuscation	Accel, Bharat Innovation Fund, Siana Capital Management	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Siana Capital Management	Yes	Series A - Zumutor Biologics	—
Siana Capital Management	Yes	Series A - Zumutor Biologics	—
Siana Capital Management	Yes	Series A - Zumutor Biologics	—
Siana Capital Management	Yes	Series A - Zumutor Biologics	—
Siana Capital Management	Yes	Series A - Zumutor Biologics	—